1. Prescribing controlled substances via telehealth. https://telehealth.hhs.gov/providers/policy-changes-during-the-covid-19-public-health-emergency/prescribing-controlled-substances-via-telehealth/. Accessed 16 Dec 2022.
2. 3/16/20-Message to substance use prevention & recovery providers—COVID-19 Frequently Asked Questions. https://www.dhs.state.il.us/page.aspx?item=123262. Accessed 15 Dec 2022.
3. Krawczyk N, Fawloe A, Yang J, Tofighi B. Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review. Addict Sci Clin Pract. 2021;16(68):1–15.
4. NIDA. Most reported substance use among adolescents held steady in 2022. National Institute on Drug Abuse website. https://nida.nih.gov/news-events/news-releases/2022/12/most-reported-substance-use-among-adolescents-held-steady-in-2022. Accessed 16 Dec 2022.
5. Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in drug overdose deaths among US adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398–400. https://doi.org/10.1001/jama.2022.2847.